Joseph A. Sparano

1991–2026 年に発表

別表記
Joseph A Sparano
148
論文数
32,504
被引用数
88
h 指数
139
i10 指数

被引用数

Joseph A. Sparano の年別被引用数1981 年: 被引用 2 件1991 年: 被引用 1 件1992 年: 被引用 1 件1993 年: 被引用 6 件1994 年: 被引用 1 件1995 年: 被引用 6 件1996 年: 被引用 4 件1997 年: 被引用 8 件1998 年: 被引用 10 件1999 年: 被引用 14 件2000 年: 被引用 12 件2001 年: 被引用 12 件2002 年: 被引用 23 件2003 年: 被引用 22 件2004 年: 被引用 33 件2005 年: 被引用 37 件2006 年: 被引用 41 件2007 年: 被引用 39 件2008 年: 被引用 98 件2009 年: 被引用 113 件2010 年: 被引用 110 件2011 年: 被引用 138 件2012 年: 被引用 118 件2013 年: 被引用 133 件2014 年: 被引用 139 件2015 年: 被引用 216 件2016 年: 被引用 291 件2017 年: 被引用 304 件2018 年: 被引用 314 件2019 年: 被引用 1,165 件2020 年: 被引用 1,495 件2021 年: 被引用 1,596 件2022 年: 被引用 1,171 件2023 年: 被引用 845 件2024 年: 被引用 1,390 件2025 年: 被引用 667 件2026 年: 被引用 21 件1982〜1990 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,725 件、この内訳の 25.1%中国: 引用元論文 1,403 件、この内訳の 9.4%イタリア: 引用元論文 855 件、この内訳の 5.7%イギリス: 引用元論文 844 件、この内訳の 5.7%ドイツ: 引用元論文 709 件、この内訳の 4.8%フランス: 引用元論文 574 件、この内訳の 3.9%カナダ: 引用元論文 503 件、この内訳の 3.4%オーストラリア: 引用元論文 477 件、この内訳の 3.2%スペイン: 引用元論文 475 件、この内訳の 3.2%ベルギー: 引用元論文 377 件、この内訳の 2.5%オランダ: 引用元論文 368 件、この内訳の 2.5%日本: 引用元論文 349 件、この内訳の 2.3%
0%25.1%その他 28.3%

分野

  • Medicine56.4%
  • Biochemistry, Genetics and Molecular Biology32.1%
  • Immunology and Microbiology4.4%
  • Computer Science2.5%
  • Materials Science1.1%
  • Engineering1%
  • その他2.5%

トピック

  • Breast Cancer Treatment Studies8.5%
  • Cancer Immunotherapy and Biomarkers6.9%
  • HER2/EGFR in Cancer Research4%
  • Immunotherapy and Immune Responses3.1%
  • Cancer Cells and Metastasis2.9%
  • Advanced Breast Cancer Therapies2.9%
  • その他71.7%

共著者

全論文

検索で開く
  1. The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Karen Willard‐Gallo, Sherene Loi - Annals of Oncology 2014 被引用: 3,136

  2. Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Joseph A. Sparano, Tanja Španić, Sandra M. Swain, Sergei Tjulandin, Masakazu Toi, Dario Trapani, Andrew Tutt, B. Xu, Giuseppe Curigliano, Nadia Harbeck - Annals of Oncology 2023 被引用: 844

  3. Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2018 被引用: 2,369

  4. Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mitch Dowsett, Frances Duane, Vaughan Evans, Marianne Ewertz, Bernard Fisher, John Forbes, Leslie G. Ford, J.-C. Gazet, Richard D. Gelber, Lucy Gettins, Luca Gianni, Michael Gnant, Jon Godwin, Aron Goldhirsch, Pamela J. Goodwin, Richard Gray, Daniel F. Hayes, Catherine Hill, James N. Ingle, Reshma Jagsi, R. Jakesz, Sam James, Wolfgang Janni, Hui Liu, Zulian Liu, Caroline Lohrisch, Sibylle Loibl, Liz MacKinnon, Andreas Makris, Eleftherios P. Mamounas, Gurdeep Mannu, Miguel Martín, S. Mathoulin, L. Mauriac, Paul McGale, Theresa McHugh, Philip Morris, Hirofumi Mukai, Larry Norton, Yasuo Ohashi, Ivo A. Olivotto, Soon Young Paik, Hongchao Pan, Richárd Pető, Martine Piccart, Lori J. Pierce, Philip Poortmans, Trevor J. Powles, K.I. Pritchard, Joseph Ragaz, Vinod Raina, Peter M. Ravdin, Simon Read, Meredith M. Regan, J.F.R. Robertson, Emiel J. Rutgers, Suzy Scholl, Dennis J. Slamon, Lidija Sölkner, Joseph A. Sparano, Seth M. Steinberg, Rosemary Sutcliffe, Sandra M. Swain, Carolyn Taylor, Andrew Tutt, Pinuccia Valagussa, Cornelis J.�H. van de Velde, Jos A. van der Hage, Giuseppe Viale, Gϋnter von Minckwitz ほか 10 名 - The Lancet Oncology 2017 被引用: 1,133

  5. Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non–Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michail Ignatiadis, Sunil Badve, Robert H. Pierce, Giuseppe Viale, Nicolas Sirtaine, Frédérique Penault‐Llorca, Tomohagu Sugie, Susan Fineberg, Soonmyung Paik, Ashok Srinivasan, Andrea L. Richardson, Yihong Wang, Ewa Chmielik, Jane Brock, Douglas B. Johnson, Justin M. Balko, Stephan Wienert, Veerle Bossuyt, Stefan Michiels, Nils Ternès, Nicole Burchardi, Stephen J. Luen, Peter Savas, Frederick Klauschen, Peter H. Watson, Brad H. Nelson, Carmen Criscitiello, Sandra A. O’Toole, Denis Larsimont, Roland de Wind, Giuseppe Curigliano, Fabrice André, Magali Lacroix‐Triki, Marc J. van de Vijver, Federico Rojo, Giuseppe Floris, Shahinaz Bedri, Joseph A. Sparano, David L. Rimm, Torsten O. Nielsen, Zuzana Kos, Stephen M. Hewitt, Baljit Singh, Gelareh Farshid, Sibylle Loibl, Kimberly H. Allison, Nadine Tung, Sylvia Adams, Karen Willard‐Gallo, Hugo M. Horlings, Leena Gandhi, André Moreira, Fred R. Hirsch, Maria Vittoria Dieci, María Urbanowicz, Iva Brčić, Konstanty Korski, Fabien Gaire, Hartmut Koeppen, Amy Lo, Jennifer M. Giltnane, Marlon C. Rebelatto, Keith E. Steele, Jiping Zha, Kenneth Emancipator, Jonathan Juco, Carsten Denkert, Jorge S. Reis‐Filho, Sherene Loi, Stephen B. Fox - Advances in Anatomic Pathology 2017 被引用: 799

  6. Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199

    著者: , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2014 被引用: 1,333

  7. Neoadjuvant trastuzumab, pertuzumab, and chemotherapy versus trastuzumab emtansine plus pertuzumab in patients with HER2-positive breast cancer (KRISTINE): a randomised, open-label, multicentre, phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2017 被引用: 529

  8. Treatment of Anal High-Grade Squamous Intraepithelial Lesions to Prevent Anal Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Grant Ellsworth, Cristina Brickman, J. Michael Berry-Lawhorn - New England Journal of Medicine 2022 被引用: 468

  9. Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further Research

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michail Ignatiadis, Sunil Badve, Robert H. Pierce, Giuseppe Viale, Nicolas Sirtaine, Frédérique Penault‐Llorca, Tomohagu Sugie, Susan Fineberg, Soonmyung Paik, Ashok Srinivasan, Andrea L. Richardson, Yihong Wang, Ewa Chmielik, Jane B. Brock, Douglas B. Johnson, Justin M. Balko, Stephan Wienert, Veerle Bossuyt, Stefan Michiels, Nils Ternès, Nicole Burchardi, Stephen J. Luen, Peter Savas, Frederick Klauschen, Peter H. Watson, Brad H. Nelson, Carmen Criscitiello, Sandra A. O’Toole, Denis Larsimont, Roland de Wind, Giuseppe Curigliano, Fabrice André, Magali Lacroix‐Triki, Marc J. van de Vijver, Federico Rojo, Giuseppe Floris, Shahinaz Bedri, Joseph A. Sparano, David L. Rimm, Torsten O. Nielsen, Zuzana Kos, Stephen M. Hewitt, Baljit Singh, Gelareh Farshid, Sibylle Loibl, Kimberly H. Allison, Nadine Tung, Sylvia Adams, Karen Willard‐Gallo, Hugo M. Horlings, Leena Gandhi, André L. Moreira, Fred R. Hirsch, Maria Vittoria Dieci, María Urbanowicz, Iva Brčić, Konstanty Korski, Fabien Gaire, Hartmut Koeppen, Amy Lo, Jennifer M. Giltnane, Marlon C. Rebelatto, Keith E. Steele, Jiping Zha, Kenneth Emancipator, Jonathan Juco, Carsten Denkert, Jorge S. Reis‐Filho, Sherene Loi, Stephen B. Fox - Advances in Anatomic Pathology 2017 被引用: 720

  10. Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jon Godwin, Sam James, Hui Liu, Elizabeth MacKinnon, Gurdeep Mannu, Theresa McHugh, Philip Morris, Simon Read, Ewan Straiton, Yaochen Wang, John Crown, Evandro de Azambuja, Suzette Delaloge, Helena Fung, Charles E. Geyer, M. Spielmann, Pinuccia Valagussa, Kathy S. Albain, Stewart Anderson, R. Arriagada, John Bartlett, Elizabeth Bergsten-Nordström, Judith M. Bliss, Étienne Brain, Lisa Carey, Robert E. Coleman, Jack Cuzick, Nancy E. Davidson, Lucia Del Mastro, Angelo Di Leo, James J. Dignam, Mitch Dowsett, Bent Ejlertsen, Prue Francis, Michael Gnant, Matthew Bidwell Goetz, Pam Goodwin, Pat Halpin-Murphy, Daniel Hayes, Catherine Hill, Reshma Jagsi, Wolfgang Janni, Sibylle Loibl, Eleftherios P. Mamounas, Miguel Martín, Hirofumi Mukai, Valentina Nekljudova, Larry Norton, Yasuo Ohashi, Lori J. Pierce, Philip Poortmans, Vinod Raina, Daniel Rea, Meredith M. Regan, J.F.R. Robertson, Emiel J. Rutgers, Tanja Španić, Joseph A. Sparano, Guenther G. Steger, Gong Tang, Masakazu Toi, Andrew Tutt, Giuseppe Viale, Xiang Wang, Timothy J. Whelan, Nicholas Wilcken, Norman Wolmark, David Cameron, Jonas Bergh, Kathleen I. Pritchard ほか 1 名 - The Lancet Oncology 2021 被引用: 348

  11. Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Toru Watanabe, Greg Yothers, Ke‐Da Yu, Richard Berry, Clare Boddington, Mike Clarke, Christina Davies, Lucy Davies, Frances Duane, Vaughan Evans, Jo Gay, Lucy Gettins, Jon Godwin, Sam James, Hui Lui, Zulian Lui, Elizabeth MacKinnon, Gurdeep Mannu, Theresa McHugh, Philip Morris, Simon Read, Ewan Straiton, Aman U. Buzdar, Vera J. Suman, Kelly K. Hunt, Robert Leonard, Janine Mansi, Catherine Delbaldo, Pascal Piedbois, Emmanuel Quinaux, Christian Fesl, Michael Gnant, Lidija Sölkner, Guenther G. Steger, Hans Petter Eikesdal, Per Eystein Lønning, Valerie Bée, Helena Fung, John R. Mackey, Miguel Martín, Michael F. Press, Evandro de Azambuja, Richard D. Gelber, Meredith M. Regan, Angelo Di Leo, Veerle Van Dooren, J.-M. Nogaret, John M.S. Bartlett, Bingshu E. Chen, Karen A. Gelmon, Paul E. Goss, Mark N. Levine, Wendy R. Parulekar, Kathleen I. Pritchard, Lois E. Shepherd, Donald A. Berry, Constance Cirrincione, Lawrence N. Shulman, Eric P. Winer, Rebecca Gelman, Jay R. Harris, Craig Henderson, Charles L. Shapiro, Peer Christiansen, Marianne Ewertz, Henning T. Mouridsen, Elise Van Leeuwen, Sabine C. Linn, Annelot G.J. van Rossum, Harm van Tinteren ほか 136 名 - The Lancet 2023 被引用: 189

  12. Current Landscape of Immunotherapy in Breast Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , - JAMA Oncology 2019 被引用: 409

  13. An emerging generation of endocrine therapies in breast cancer: a clinical perspective

    著者: , , , - npj Breast Cancer 2023 被引用: 129

  14. Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2019 被引用: 555

  15. Proposal for Standardized Definitions for Efficacy End Points in Adjuvant Breast Cancer Trials: The STEEP System

    著者: , , , , , , , , , , - Journal of Clinical Oncology 2007 被引用: 885

  16. Prospective Validation of a 21-Gene Expression Assay in Breast Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , George W. Sledge - New England Journal of Medicine 2015 被引用: 1,439

  17. Neoadjuvant chemotherapy induces breast cancer metastasis through a TMEM-mediated mechanism

    著者: , , , , , , , , , , , , , , , - Science Translational Medicine 2017 被引用: 508

  18. Neoadjuvant Trastuzumab Emtansine and Pertuzumab in Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Three-Year Outcomes From the Phase III KRISTINE Study

    著者: , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2019 被引用: 248

  19. Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jeroen van der Laak, Francesco Ciompi, Anne‐Vibeke Lænkholm, Enrique Bellolio, Tina Gruosso, Stephen B. Fox, Juan Carlos Araya, Giuseppe Floris, Jan Hudeček, Leonie Voorwerk, Andrew H. Beck, J. Kaplan Kerner, Denis Larsimont, Sabine Declercq, Gert Van den Eynden, Lajos Pusztai, Anna Ehinger, Wentao Yang, Khalid AbdulJabbar, Yinyin Yuan, Rajendra Singh, Crispin T. Hiley, Maise Al Bakir, Alexander J. Lazar, Stephen P. Naber, Stephan Wienert, Miluska Castillo, Giuseppe Curigliano, Maria Vittoria Dieci, Fabrice André, Charles Swanton, Jorge S. Reis‐Filho, Joseph A. Sparano, Eva Balslev, I‐Chun Chen, Elisabeth Ida Specht Stovgaard, Katherine L. Pogue–Geile, Kim Blenman, Frédérique Penault–Llorca, Stuart J. Schnitt, Sunil R. Lakhani, Anne Vincent‐Salomon, Federico Rojo, Jeremy Braybrooke, Matthew G. Hanna, María Teresa Soler-Monsó, Daniel Bethmann, Carlos Castaneda, Karen Willard‐Gallo, Ashish Sharma, Huang‐Chun Lien, Susan Fineberg, Jeppe Thagaard, Laura Comerma, Paula I. González-Ericsson, Edi Brogi, Sherene Loi, Joel Saltz, Frederick Klaushen, Lee Cooper, Mohamed Amgad, David Moore, Roberto Salgado, the International Immuno-Oncology Biomarker Working Group, Aini Hyytiäinen, Akira I. Hida, Alastair Thompson, Alexis Lefevre, Allen M. Gown, Amy Lo ほか 156 名 - npj Breast Cancer 2020 被引用: 206

  20. Weekly Paclitaxel in the Adjuvant Treatment of Breast Cancer

    著者: , , , , , , , , , - New England Journal of Medicine 2008 被引用: 1,029

  21. If we build it they will come: targeting the immune response to breast cancer

    著者: , , , , , , , , , , , , , , , , - npj Breast Cancer 2019 被引用: 208

  22. Progress in adjuvant chemotherapy for breast cancer: an overview

    著者: , , - BMC Medicine 2015 被引用: 371

  23. Association of Circulating Tumor Cells With Late Recurrence of Estrogen Receptor–Positive Breast Cancer

    著者: , , , , , , , - JAMA Oncology 2018 被引用: 199

  24. Randomized Phase II Trial of Fulvestrant Plus Everolimus or Placebo in Postmenopausal Women With Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer Resistant to Aromatase Inhibitor Therapy: Results of PrE0102

    著者: , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2018 被引用: 189